NGS-HPC: Hereditary predisposition to prostate cancer: Identification of heritability by discovering by combining exome sequencing and haplotype analysis in a population with strong effect (Q2906214): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 85.0 percentage) |
(Added qualifier: readability score (P590521): 0.000011549073841409742) |
||||||||||||||
| (3 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / start time | |||||||||||||||
| |||||||||||||||
| Property / start time: 1 July 2016 / rank | |||||||||||||||
| Property / end time | |||||||||||||||
| |||||||||||||||
| Property / end time: 1 July 2019 / rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
| Property / beneficiary name (string): INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E. / rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: Q2997125 (Deleted Item) / rank | |||||||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||||||
| 166,625.5 Euro
| ||||||||||||||
| Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549073841409742
| |||||||||||||||
| Property / priority axis | |||||||||||||||
| Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
85.0 percent
| |||||||||||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / thematic objective | |||||||||||||||
| Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / start time | |||||||||||||||
7 January 2016
| |||||||||||||||
| Property / start time: 7 January 2016 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / end time | |||||||||||||||
7 January 2019
| |||||||||||||||
| Property / end time: 7 January 2019 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E. | |||||||||||||||
| Property / beneficiary name (string): INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
14 November 2023
| |||||||||||||||
| Property / date of last update: 14 November 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 10:56, 22 March 2024
Project Q2906214 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NGS-HPC: Hereditary predisposition to prostate cancer: Identification of heritability by discovering by combining exome sequencing and haplotype analysis in a population with strong effect |
Project Q2906214 in Portugal |
Statements
166,625.5 Euro
0 references
196,030.0 Euro
0 references
85.0 percent
0 references
7 January 2016
0 references
7 January 2019
0 references
INSTITUTO PORTUGUÊS DE ONCOLOGIA DO PORTO FRANCISCO GENTIL - E.P.E.
0 references
14 November 2023
0 references
Identifiers
POCI-01-0145-FEDER-016889
0 references